Document is current
Any future updates will be listed below
-
Authors
Cour, Martin https://orcid.org/0000-0003-4909-9761
Klouche, Kada
Souweine, Bertrand
Quenot, Jean-Pierre
Schwebel, Carole
Perinel, Sophie
Amaz, Camille
Buisson, Marielle
Ovize, Michel
Mewton, Nathan
Argaud, Laurent
,
Hernu, Romain
Gragueb-Chebib, Inesse
Baudry, Thomas
Madelaine, Thomas
Machado, Sonia
Jung, Boris
Coupez, Elizabeth
Lautrette, Alexandre
Dargent, Auguste
Terzi, Nicolas
Zeni, Fabrice
Thiery, Guillaume
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct03201575 at ClinicalTrials.govDocuments that mention this clinical trial
Remote ischemic conditioning in septic shock: the RECO-Sepsis randomized clinical trial
https://doi.org/10.1007/s00134-022-06872-1
-
Funding
Funding for this research was provided by:
French Ministry of Health (PHRCI-2016)
- License Information
-
More Information
Article History
Received: 31 May 2022
Accepted: 18 August 2022
First Online: 14 September 2022
Declarations
:
: The authors declare they have no conflict of interest, including financial interests, activities, relationships, and affiliations in relation with the RECO-Sepsis trial.
: The trial was authorized by the French national drug agency on 23 August 2017 and was also approved by an Ethics Committee (Comité de Protection des Personnes CCP Ile-de-France X) on 5 September 2017 (n°2017-A01684-49) and was registered in ClinicalTrials before the start of the study (NCT03201575). The trial was conducted according to the requirements of the Declaration of Helsinki. Written informed consent was obtained from all participants or their closest relatives (in cases of impaired decision-making capacity) at the time of enrollment.
